Abstract
Recent analysis on polypharmacology leads to the idea that only small fragments of drugs and targets are a key to understanding their interactions forming polypharmacology. This idea motivates us to build an in silico approach of finding significant substructure patterns from drug–target (molecular graph–amino acid sequence) pairs. This article introduces an efficient in silico method for enumerating, from given drug–target pairs, all frequent subgraph–subsequence pairs, which can then be further examined by hypothesis testing for statistical significance. Unique features of the method are its scalability, computational efficiency, and technical soundness in terms of computer science and statistics. The presented method was applied to 11,219 drug–target pairs in DrugBank to obtain significant substructure pairs, which can divide most of the original 11,219 pairs into eight highly exclusive clusters, implying that the obtained substructure pairs are indispensable components for interpreting polypharmacology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Apsel B, Blair J, Gonzalez B, Nazif T, Feldman M, Aizenstein B, Hoffman R, Williams R, Shokat K, Knight Z (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol 4:691–699
Campillos M, Kuhn M, Gavin A, Jensen L, Bork P (2008) Drug target identification using side-effect similarity. Science 321:263–266
Frantz S (2005) Drug discovery: playing dirty. Nature 437:942–943
Yildirim M, Goh K, Cusick M, Barabasi A, Vidal M (2007) Drug-target network. Nat Biotechnol 25:1119–1126
Morphy R, Rankovic Z (2007) Fragments, network biology and designing multiple ligands. Drug Discov Today 12:156–160
Hopkins A (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682–690
Paolini G, Shapland R, van Hoorn W, Mason J, Hopkins A (2006) Global mapping of pharmacological space. Nat Biotechnol 24:805–815
Takigawa I, Tsuda K, Mamitsuka H (2011) Mining significant substructure pairs for interpreting polypharmacology in drug-target network. PLoS One 6(2):e16999
Wishart D, Knox C, Guo A, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 36:D901–D906
Han J, Cheng H, Dong X, Yan X (2007) Frequent pattern mining: current status and future directions. Data Min Knowl Discov 15(1):55–86
Cordell H (2002) Epistasis: what it means, what it doesn’t mean, and statistical methods to detect it in humans. Hum Mol Genet 11:2463–2468
Pei J, Han J, Mortazavi-Asl B, Wan J, Pinto H, Chen Q, Dayal U, Hsu M-C (2004) Mining sequential patterns by pattern-growth: the PrefixSpan approach. IEEE Trans Knowl Data Eng 16(11):1424–1440
Yan X, Han J (2002) gSpan: graph-based substructure pattern mining. In: IEEE International Conference on Data Mining (ICDM’02), Washington, DC, USA, 9-12, December pp. 721–724
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Takigawa, I., Tsuda, K., Mamitsuka, H. (2013). An In Silico Model for Interpreting Polypharmacology in Drug–Target Networks. In: Kortagere, S. (eds) In Silico Models for Drug Discovery. Methods in Molecular Biology, vol 993. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-342-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-342-8_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-341-1
Online ISBN: 978-1-62703-342-8
eBook Packages: Springer Protocols